Stocks and Investing Stocks and Investing
Tue, April 25, 2023

Steve Valiquette Upgraded (UHS) to Hold and Increased Target to $142 on, Apr 25th, 2023


Published on 2024-10-28 03:00:28 - WOPRAI, Steve Valiquette
  Print publication without navigation


Steve Valiquette of Barclays, Upgraded "Universal Health Services, Inc." (UHS) to Hold and Increased Target from $132 to $142 on, Apr 25th, 2023.

Steve has made no other calls on UHS in the last 4 months.



There are 11 other peers that have a rating on UHS. Out of the 11 peers that are also analyzing UHS, 7 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Mok of "UBS" Maintained at Hold with Decreased Target to $155 on, Wednesday, April 19th, 2023
  • Calvin Sternick of "JP Morgan" Initiated at Hold and Held Target at $133 on, Wednesday, April 19th, 2023
  • Stephen Baxter of "Wells Fargo" Maintained at Hold with Decreased Target to $138 on, Monday, March 6th, 2023
  • Justin Lake of "Wolfe Research" Downgraded from Buy to Hold on, Wednesday, March 1st, 2023
  • Ben Hendrix of "RBC Capital" Maintained at Hold with Increased Target to $130 on, Wednesday, March 1st, 2023
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $140 on, Wednesday, March 1st, 2023
  • Kevin Fischbeck of "B of A Securities" Maintained at Hold and Held Target at $160 on, Tuesday, February 28th, 2023


These are the ratings of the 4 analyists that currently disagree with Steve


  • Sarah James of "Cantor Fitzgerald" Initiated at Sell and Held Target at $143 on, Friday, April 21st, 2023
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $140 on, Monday, March 6th, 2023
  • Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $145 on, Monday, March 6th, 2023
  • Jonathan Yon of "Credit Suisse" Maintained at Buy with Decreased Target to $153 on, Friday, March 3rd, 2023
Contributing Sources